Related Experiment Videos
Ceftazidime and cefotaxime--the clinician's choice
S D Puthucheary1, P J Goldsworthy
1Department of Medical Microbiology, University of Malaya, Kuala Lumpur.
Clinical Therapeutics
|March 1, 1989
Summary
Ceftazidime and cefotaxime are third-generation cephalosporins effective against various infections, including meningitis. Ceftazidime shows broader activity against Pseudomonas species, while both are safe for all age groups.
Area of Science:
- Pharmacology
- Infectious Diseases
Background:
- Third-generation cephalosporins represent an advancement over earlier generations.
- Ceftazidime and cefotaxime are key antibiotics in this class.
Purpose of the Study:
- To review and compare the efficacy and safety of ceftazidime and cefotaxime.
- To highlight their utility in treating various bacterial infections.
Main Methods:
- Literature review of clinical studies on ceftazidime and cefotaxime.
- Comparative analysis of antimicrobial activity and clinical outcomes.
Main Results:
- Ceftazidime demonstrates superior activity against Pseudomonas aeruginosa and Enterobacteriaceae compared to cefotaxime.
- Both antibiotics are effective in treating meningitis due to cerebrospinal fluid penetration.
- Ceftazidime is effective as monotherapy for certain infections, while cefotaxime is often used with aminoglycosides.
- Both drugs exhibit favorable safety profiles and are suitable for pediatric and adult use.
Conclusions:
- Ceftazidime and cefotaxime are valuable third-generation cephalosporins with distinct activity profiles.
- Their efficacy in meningitis and broad applicability across age groups underscore their importance in clinical practice.